YHYuanyuan Huang

Yuanyuan Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yuanyuan Huang has a total of 66 co-authors. Here are the top co-authors by number of shared publications:

  • Fengchun Wu

    The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China

    6 shared publications
  • Kai Wu

    School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou, China

    4 shared publications
  • Xiang Yang Zhang

    State Key Laboratory of Cognitive Science and Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing, China

    3 shared publications
  • Hehua Li

    Department of Psychiatry, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, People’s Republic of China

    2 shared publications
  • Hongbo He

    Department of Psychiatry, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, People’s Republic of China

    2 shared publications
  • Mingzhe Yang

    Department of Psychiatry, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, People’s Republic of China

    2 shared publications

Latest Publications

  • Transcriptional Patterns of Disruption in Structure–Function Coupling in First-episode, Drug-naive Major Depressive Disorder

    by Minxin Guo, Ryan Zhu, Heng Zhang, Wei Wang, Yuanyuan Huang, Yunheng Diao, Zhaobo Li, Xin Zhang, Jing Zhou, Yuping Ning, et al.

  • Open Access

    Disordered eating attitudes in hospitalized schizophrenia patients of Guangdong, China: prevalence, associated factors, and the exploratory mediating role of insight in the depression-eating attitude link

    by Gang Zeng, Xiezhen Chen, Zangrui Niu, Fengchun Wu, Xiaodong Chen, Cuixia Liu, Xiaolei Shi, Yuanyuan Huang, Wenqing Zhou, Weiye Cao, et al.

  • Open Access

    Efficacy of Acupuncture Combined With Pharmacotherapy for Depression: A Randomized Controlled Clinical Trial

    by Shuyun Huang, Sumiao Zhou, Lida Zhang, Fengchun Wu, Zhendong Zhang, Yuping Ning, Zixuan Liu, Jingping Wu, Bingxin Chen, Qiuling Lu, et al.

    Background:Depression is frequently accompanied by comorbid symptoms such as anxiety, insomnia, and cognitive impairment, which complicate treatment and adversely affect clinical outcomes. Acupuncture has shown promise as a complementary therapy; however, the efficacy of acupuncture combined with selective serotonin reuptake inhibitors (SSRIs) requires further investigation.Methods:This single-center, randomized clinical trial enrolled 213 inpatients with depression and comorbid symptoms. Participants were randomly assigned to receive either SSRIs treatment or antidepressant treatment combined with acupuncture for two weeks. Clinical outcomes were assessed using the Hamilton Depression Rating Scale (HAMD), Hamilton Anxiety Rating Scale (HAMA), Mini-Mental State Examination (MMSE), Pittsburgh Sleep Quality Index (PSQI), and Beck Scale for Suicide Ideation (BSI). The primary outcome was the change in the HAMD reduction rate.Results:Both groups demonstrated significant clinical improvement after two weeks of treatment. However, analysis of covariance (ANCOVA) revealed that the acupuncture group achieved significantly greater reductions in HAMD, HAMA, and PSQI scores, as well as significantly higher MMSE scores, compared with the control group (all adjusted p < 0.05). Hierarchical regression analyses indicated that baseline symptom severity and duration of illness were significant predictors of treatment response.Conclusions:When used as an adjunct to antidepressant therapy, acupuncture provides rapid and broad therapeutic benefits for patients with depression. Compared with SSRI monotherapy, the combined treatment was associated with greater improvements in depressive and anxiety symptoms, sleep quality, and cognitive performance. These findings support the integration of acupuncture into multimodal treatment strategies for managing the complex symptom profile of major depressive disorder.Clinical Trial Registration:The study has been registered on https://itmctr.ccebtcm.org.cn/en/index.html (registration number: ITMCTR2025001802; registration link: https://trialsearch.who.int/Trial2.aspx?TrialID=ITMCTR2025001802).


  • Open Access

    Differences in the Association of Anxiety, Insomnia and Somatic Symptoms between Medical Staff and the General Population During the Outbreak of COVID-19

    by Yuanyuan Huang, Yongjie Zhou, Yi Wei, Lingyun Zeng, Jiezhi Yang, Yi Li, Xiuli Song, Hehua Li, Hongbo He, Ting Li, et al.

    Background: During the outbreak of coronavirus disease 2019 (COVID-19), occupational differences were recognized with respect to psychological issues, but there are no reports regarding the insomnia and anxiety comorbidities and their related factors among the general public and medical staff. Our study aimed to compare the prevalence of anxiety and anxiety with insomnia, as well as the relationship between different psychological symptoms between the two groups. Methods: A total of 605 medical staff and 1091 public respondents were assessed through an online questionnaire survey, including the 7-item Insomnia Severity Index (ISI), the somatization subscale of Symptom Checklist 90-Revised (SCL-90-R), and the 7-item Generalized Anxiety Disorder scale (GAD-7). Results: Compared with the general public, medical staff had a higher incidence of anxiety (45.5% vs 32.4%). The incidence of insomnia in anxious participants was 52.7% in medical staff and 44.6% in the general public, and the difference was significant (p < 0.05). The GAD-7 score and somatization subscore of the SCI-90 were independently associated with insomnia among anxiety participants in both groups (all p < 0.001). Conclusion: Our findings suggest that during the epidemic period of COVID-19, medical staff experienced more anxiety and anxiety with insomnia. Somatization, anxiety and insomnia are highly correlated among medical staff and the general public.


  • Open Access

    The Relationship Between Symptoms of Anxiety and Somatic Symptoms in Health Professionals During the Coronavirus Disease 2019 Pandemic

    by Hehua Li, Yaping Zhang, Honggang Wang, Jing Liang, Yongjie Zhou, Yuanyuan Huang, Tianyi Zhai, Qiong Yang, Mingzhe Yang, Yuping Ning, et al.

    Background: The pandemic of coronavirus disease 2019 (COVID-19) has posed a threat to global health. Increasing studies have shown that the mental health status of health professionals is very poor during the COVID-19 epidemic. At present, the relationship between somatic symptoms and symptoms of anxiety of health professionals during the COVID-19 has not been reported. The purpose of this study was to explore the frequency of somatic symptoms and its related factors in health professionals with symptoms of anxiety during COVID-19 in China. Methods: A total of 606 health professionals were assessed online with the Chinese version of the 7-item Generalized Anxiety Disorder (GAD-7) scale, 7-item Insomnia Severity Index (ISI) and the somatization subscale of Symptom Checklist 90 (SCL-90). Results: The percentage of symptoms of anxiety, somatic symptoms and insomnia in all health professionals was 45.4%, 12.0%, and 32%, respectively. The frequency of somatic symptoms in health professionals with symptoms of anxiety was 22.9%. The SCL-90 somatization subscale score was significantly positively correlated with history of somatic diseases, GAD-7 score and ISI score in participants with symptoms of anxiety. Conclusion: During the COVID-19, symptoms of anxiety, insomnia, and somatic symptoms are commonly observed in health professionals. Insomnia and symptoms of anxiety are independently associated with somatic symptoms of health professionals with symptoms of anxiety.


  • Open Access

    Homocysteine level, body mass index and clinical correlates in Chinese Han patients with schizophrenia

    by Yuanyuan Huang, Kai Wu, Hehua Li, Jing Zhou, Dongsheng Xiong, Xia Huang, Jiahui Li, Ya Liu, Zhilin Pan, David T. Mitchell, et al.

    Obesity is common comorbidity in patients with schizophrenia. Previous studies have reported that homocysteine (Hcy) is increased in schizophrenia. However, no study has reported the association between BMI and Hcy levels in schizophrenia. This cross-sectional naturalistic study aimed to evaluate the relationship between BMI, Hcy and clinical symptoms in Chinese Han patients with chronic schizophrenia. Clinical and anthropometric data as well as plasma Hcy level and glycolipid parameters were collected. Psychopathology was measured with the Positive and Negative Syndrome Scale (PANSS). Our results showed that compared with the low BMI group, the high BMI group had a higher PANSS general psychopathology subscore, higher levels of blood glucose, total cholesterol and high-density lipoprotein (HDL) cholesterol (all p < 0.05). Hcy levels were negatively associated with BMI in patients (p < 0.001). Hcy level, the PANSS general psychopathology subscale, total cholesterol and education (all p < 0.05) were the influencing factors of high BMI. Our study suggest that Hcy level may be associated with BMI in patients with schizophrenia. Moreover, patients with high BMI show more severe clinical symptoms and higher glucose and lipid levels.


  • Comparison of Quantitative Characteristics of Early Post-resuscitation EEG Between Asphyxial and Ventricular Fibrillation Cardiac Arrest in Rats

    by Bihua Chen, Gang Chen, Chenxi Dai, Pei Wang, Lei Zhang, Yuanyuan Huang, Yongqin Li

    Background Quantitative electroencephalogram (EEG) analysis has shown promising results in studying brain injury and functional recovery after cardiac arrest (CA). However, whether the quantitative characteristics of EEG, as potential indicators of neurological prognosis, are influenced by CA causes is unknown. The purpose of this study was designed to compare the quantitative characteristics of early post-resuscitation EEG between asphyxial CA (ACA) and ventricular fibrillation CA (VFCA) in rats. Methods Thirty-two Sprague–Dawley rats of both sexes were randomized into either ACA or VFCA group. Cardiopulmonary resuscitation was initiated after 5-min untreated CA. Characteristics of early post-resuscitation EEG were compared, and the relationships between quantitative EEG features and neurological outcomes were investigated. Results Compared with VFCA, serum level of S100B, neurological deficit score and brain histopathologic damage score were dramatically higher in the ACA group. Quantitative measures of EEG, including onset time of EEG burst, time to normal trace, burst suppression ratio, and information quantity, were significantly lower for CA caused by asphyxia and correlated with the 96-h neurological outcome and survival. Conclusions Characteristics of earlier post-resuscitation EEG differed between cardiac and respiratory causes. Quantitative measures of EEG not only predicted neurological outcome and survival, but also have the potential to stratify CA with different causes.